Gilead Sciences Pops On A New $4 Billion Opportunity In HIV Prevention
Investor's Business DailyGilead stock popped Thursday after the biotech giant said its twice-yearly shot prevented 99.9% of HIV infections in a study.
The post Gilead Sciences Pops On A New $4 Billion Opportunity In HIV Prevention appeared first on Investor's Business Dai…